Search
for

    Sort by

    Research 331–360 of 339

    1. 573 Discovery of JW0061, a novel GFRA1 agonist, as a hair regeneration stimulant via WNT signaling activation in dermal papilla cells Journal of Investigative Dermatology · 2024
    2. [RETRACTED] FoliPrime Reviews: Will Foli Prime Hair Support Formula Work for You? v1 2022
    3. [RETRACTED] FoliPrime Serum Reviews – Is Foli Prime Legit or Cheap Supplement Brand? v1 2022
    4. [RETRACTED] FoliPrime Reviews: Ingredients, Side Effects, Pros & Cons Here! v1 2022
    5. [RETRACTED] Folicrex: Know This First Before Buying Hair Regrowth Pills? v1 2022
    6. [RETRACTED] Folicrex: Know This First Before Buying Hair Regrowth Pills? v1 2022
    7. Restolin Hair Supplement: Here are Some Effective Remedies for Hair Fall Control! v1 2022
    8. [RETRACTED] Restolin Hair Supplement: Here are Some Effective Remedies for Hair Fall Control! v1 2022
    9. [RETRACTED] Restolin Reviews Amazon: UK, USA, Australia, South Africa, Canada, NZ (Ingredients Updates) v1 2022
    10. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review Cureus · 2025
    11. GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions 2025
    12. Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy · 2025 · 1 citations
    13. Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face” Dermatology and Therapy · 2026
    14. Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review International Journal of Dermatology · 2025
    15. Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review Cureus · 2025
    16. 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations Journal of the American Academy of Dermatology · 2026
    17. Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends JEADV Clinical Practice · 2025
    18. Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey Journal of Cosmetic Dermatology · 2026
    19. Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review Skin Appendage Disorders · 2025
    20. Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review Wound Repair and Regeneration · 2025
    21. Supplementary Material for: GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms Figshare · 2026
    22. Supplementary Material for: GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms Figshare · 2026
    23. “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services Nutrition Bulletin · 2024
    24. GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms Skin Appendage Disorders · 2026
    25. Are Pediatric GLP ‐1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age‐Specific Patterns and Their Implications for Dermatologists Pediatric Dermatology · 2026 · 1 citations
    26. Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study Journal of the American Academy of Dermatology · 2025 · 31 citations
    27. Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review Cureus · 2024 · 5 citations
    28. Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes Journal of Clinical Medicine · 2026
    29. Clinical and mechanistic effects of GLP-1 receptor agonists in hidradenitis suppurativa and comorbidities Science Progress · 2026
    30. Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists Frontiers in Nutrition · 2026